Katarzyna Kotfis

Professor Katarzyna Kotfis is a full Professor of Anaesthesiology and Intensive Care at the Pomeranian Medical University in Szczecin, Poland, serving within the Department of Anaesthesiology, Intensive Care and Pain Management of the Faculty of Medicine since 2021. She previously worked as Professor Assistant (2019–2021) and obtained her doctoral degree in 2011. Her scientific profile is anchored 100 % in medical sciences, with an extensive publication record of 181 peer-reviewed works and an Hirsch index calculated by the university repository.

Education & Career Milestones:

• Doctor of Medical Sciences – 2011
• Professor Assistant – 2019
• Full Professor – 2021 (current)

Research Interests:
Professor Kotfis leads wide-ranging investigations that converge on improving outcomes for critically ill and surgical patients. Her core themes revolve around peri-operative risk stratification—especially in patients with chronic heart failure or obesity—post-operative delirium and post-intensive care syndrome, COVID-19 critical care pathophysiology, and the brain–heart–kidney axis. She also explores novel therapeutic avenues including phytochemicals such as xanthohumol, AI-assisted delirium detection, and the renin–angiotensin–aldosterone system in sepsis.

Scientific Awards & Recognitions:

• Repository-listed Achievement #1
• Repository-listed Achievement #2
• Repository-listed Achievement #3
• Repository-listed Achievement #4
• Repository-listed Achievement #5

Supervision & Research Leadership:
She has successfully promoted 5 doctoral theses and currently leads 2 active research projects. Her team participates in large international consortia such as MET-REPAIR and VIP2, focusing on multi-centre cohort studies that shape evidence-based guidelines in anaesthesiology and critical care.

Laboratory & Collaborative Networks:
While no single named laboratory is specified, her work involves collaboration across clinical ICUs, biobanks, genomic/microbiome platforms, and international research networks spanning Europe, Latin America and the Middle East, ensuring translational impact from bench to bedside.